Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
1.285
+0.025 (1.98%)
Jul 24, 2026, 9:42 AM EDT - Market open
Daré Bioscience Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 |
| 0.15 | 1.02 | 0 | -0.02 | 0.03 | -0.06 | 0.04 | 0.02 | 0.01 | 1.81 | 1 | - | - | 0 | - | 10 | - | - | - | - | |
Revenue Growth (YoY) | 499.58% | - | -94.57% | - | 173.35% | - | -95.83% | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue | 0.24 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit | -0.09 | 1.02 | 0 | -0.02 | 0.03 | -0.06 | 0.04 | 0.02 | 0.01 | 1.81 | 1 | - | - | 0 | - | 10 | - | - | - | - |
Selling, General & Admin | 2.25 | 1.58 | 2.5 | 2.38 | 2.31 | 2 | 2.04 | 2.45 | 2.67 | 3.15 | 2.7 | 2.92 | 3.34 | 3.23 | 2.65 | 2.79 | 2.57 | 2.4 | 2.21 | 1.8 |
Research & Development | 0.66 | 0.62 | 1.18 | 1.43 | 2.3 | 3.34 | 2.68 | 4.93 | 3.35 | 3.8 | 6.67 | 6.04 | 5.02 | 12.98 | 4.46 | 6.8 | 5.81 | 7.12 | 10.43 | 7.34 |
Other Operating Expenses | - | - | - | - | - | - | - | - | 0.01 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
Total Operating Expenses | 2.91 | 2.2 | 3.67 | 3.81 | 4.61 | 5.33 | 4.72 | 7.38 | 6.03 | 6.98 | 9.4 | 8.99 | 8.38 | 16.23 | 7.14 | 9.62 | 8.4 | 9.54 | 12.67 | 9.16 |
Operating Income | -3 | -1.47 | -3.67 | -3.83 | -4.58 | -5.39 | -4.68 | -7.36 | -6.02 | -5.17 | -8.4 | -8.99 | -8.38 | -16.23 | -7.14 | 0.38 | -8.4 | -9.54 | -12.67 | -9.16 |
Total Non-Operating Income (Expense) | -0 | - | 0.11 | -0.19 | 0.2 | 0 | -0.02 | 20.38 | -0.73 | - | 0.1 | 0.23 | 0.34 | 0.29 | 0.12 | 0.03 | 0 | 0 | 0 | 0 |
Pretax Income | -3 | -1.47 | -3.56 | -4.02 | -4.38 | -5.39 | -4.7 | 13.02 | -6.76 | -5.17 | -8.3 | -8.76 | -8.04 | -15.94 | -7.02 | 0.41 | -8.4 | -9.54 | -12.67 | -9.16 |
Net Income | -3 | -1.44 | -3.56 | -4.02 | -4.38 | -5.51 | -4.7 | 12.91 | -6.76 | -5.06 | -8.3 | -8.76 | -8.04 | -15.94 | -7.02 | 0.41 | -8.4 | -9.54 | -12.67 | -9.16 |
Net Income to Common | -3 | -1.44 | -3.56 | -4.02 | -4.38 | -5.51 | -4.7 | 12.91 | -6.76 | -5.06 | -8.3 | -8.76 | -8.04 | -15.94 | -7.02 | 0.41 | -8.4 | -9.54 | -12.67 | -9.16 |
Shares Outstanding (Basic) | 15 | 14 | 13 | 9 | 9 | 8 | 9 | 8 | 8 | 7 | 8 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 6 | 4 |
Shares Outstanding (Diluted) | 15 | 14 | 13 | 9 | 9 | 8 | 9 | 8 | 8 | 7 | 8 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 6 | 4 |
Shares Change (YoY) | 65.80% | 78.14% | 49.45% | 4.66% | 4.57% | 9.92% | 12.48% | 17.72% | 17.54% | 5.10% | 7.34% | 1.21% | 1.87% | 4.13% | 19.85% | 69.26% | 88.63% | 109.31% | 124.06% | 88.83% |
EPS (Basic) | -0.21 | -0.02 | -0.28 | -0.45 | -0.50 | -0.65 | -0.55 | -1.53 | -0.81 | -0.70 | -1.09 | -1.22 | -1.08 | -1.20 | -0.96 | - | -1.20 | -1.44 | -2.16 | -2.16 |
EPS (Diluted) | -0.21 | -0.02 | -0.28 | -0.45 | -0.50 | -0.65 | -0.55 | -1.53 | -0.81 | -0.70 | -1.09 | -1.22 | -1.08 | -1.20 | -0.96 | - | -1.20 | -1.44 | -2.16 | -2.16 |
Free Cash Flow | -5.52 | 1.24 | -0.62 | -5.26 | -5.63 | 4.74 | -5.64 | 12.62 | -6.82 | -8.79 | -8 | -6.59 | -16.12 | -5.9 | 8.55 | -8.45 | -12.35 | -9.92 | 1.31 | -11.79 |
Free Cash Flow Growth | - | -73.91% | - | - | - | - | - | - | - | - | - | - | - | - | 554.40% | - | - | - | - | - |
Free Cash Flow Per Share | -0.38 | 0.09 | -0.05 | -0.59 | -0.64 | 0.59 | -0.66 | 1.49 | -0.81 | -1.20 | -1.05 | -0.91 | -2.26 | -0.85 | 1.21 | -1.19 | -1.77 | -1.49 | 0.22 | -2.81 |
Gross Margin | -58.95% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | - | - | - | - | 100.00% | - | - | - | - |
Operating Margin | -1967.07% | -143.72% | -162341.00% | 18079.50% | -18016.70% | 8465.75% | -11228.70% | -32799.10% | -64743.90% | -286.05% | -839.64% | - | - | - | - | 3.84% | - | - | - | - |
Profit Margin | -1967.72% | -140.84% | -157505.00% | 18970.70% | -17219.10% | 8651.47% | -11279.40% | 57539.20% | -72622.60% | -279.75% | -829.91% | - | - | - | - | 4.14% | - | - | - | - |
FCF Margin | -3621.16% | 120.90% | -27269.50% | 24863.30% | -22133.50% | -7452.15% | -13532.30% | 56241.50% | -73320.30% | -486.00% | -799.59% | - | - | - | - | -84.49% | - | - | - | - |
EBITDA | -2.44 | -0.94 | -3.19 | -3.37 | -4.41 | -5.38 | -4.67 | -7.34 | -6.01 | -5.16 | -8.39 | -8.98 | -8.37 | -16.22 | -7.14 | 0.39 | -8.4 | -9.54 | -12.66 | -9.16 |
EBITDA Margin | -1603.26% | -91.52% | -141036.00% | 15906.50% | -17326.00% | 8455.75% | -11205.30% | -32730.30% | -64628.00% | -285.50% | -838.72% | - | - | - | - | 3.90% | - | - | - | - |
EBIT | -3 | -1.47 | -3.67 | -3.83 | -4.58 | -5.39 | -4.68 | -7.36 | -6.02 | -5.17 | -8.4 | -8.99 | -8.38 | -16.23 | -7.14 | 0.38 | -8.4 | -9.54 | -12.67 | -9.16 |
EBIT Margin | -1967.07% | -143.72% | -162341.00% | 18079.50% | -18016.70% | 8465.75% | -11228.70% | -32799.10% | -64743.90% | -286.05% | -839.64% | - | - | - | - | 3.84% | - | - | - | - |